Paushak Ltd

Paushak Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Paushak Ltd

₹ 6,282 -0.09%
29 Mar 4:01 p.m.
paushak.com BSE: 532742
About

Paushak is India’s largest phosgene based specialty chemicals manufacturer serving pharmaceutical, agrochemical and performance industries. Paushak is part of the Alembic group of companies situated in Gujarat, India. Alembic Ltd is the oldest pharmaceutical company in India founded in 1907. [1][2]

Key Points

Revenue Mix - FY22
The company derives revenue from chloroformates, isocyanates, specialty chemicals, carbonates and phosgene gas. [1] The geographic distribution is as follows:
India - 78%
Outside India - 22% [2]

Website BSE
  • Market Cap ₹ 1,936 Cr.
  • Current Price ₹ 6,282
  • High / Low ₹ 12,400 / 6,243
  • Stock P/E 37.5
  • Book Value ₹ 1,060
  • Dividend Yield 0.19 %
  • ROCE 16.9 %
  • ROE 12.6 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company is expected to give good quarter

Cons

  • Dividend payout has been low at 6.69% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
38 29 32 30 40 39 23 41 34 53 50 50 56
24 21 22 20 26 22 18 23 22 32 32 33 35
Operating Profit 14 8 10 10 14 16 5 18 12 20 18 17 20
OPM % 36% 27% 32% 33% 35% 42% 21% 43% 34% 39% 37% 33% 37%
2 1 1 1 3 1 1 3 0 1 1 5 3
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 1 1 1 1 1 1 1 2 3 3 3 3 3
Profit before tax 14 8 10 9 16 16 4 19 9 18 16 18 20
Tax % 23% 22% 17% 34% 26% 32% 27% 26% 23% 26% 27% 27% 24%
Net Profit 11 6 9 6 12 11 3 14 7 13 12 13 15
EPS in Rs 35.75 20.67 28.00 19.82 37.44 35.72 9.51 46.33 23.30 42.89 37.47 42.47 48.73
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
30 34 51 54 69 78 72 105 140 138 141 150 208
24 29 39 43 52 61 60 75 99 95 91 96 133
Operating Profit 6 5 12 11 17 17 12 29 40 43 50 54 76
OPM % 20% 15% 23% 20% 25% 22% 17% 28% 29% 31% 36% 36% 36%
1 1 1 4 3 3 5 3 13 7 6 5 9
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 2 2 2 2 2 3 3 3 4 4 5 9 13
Profit before tax 5 4 11 13 18 17 14 29 49 45 52 50 71
Tax % 23% 17% 27% 30% 28% 25% 22% 26% 20% 23% 28% 25%
Net Profit 4 3 8 9 13 12 11 21 39 35 37 38 53
EPS in Rs 11.54 10.76 24.29 27.50 40.50 38.73 34.11 66.95 126.41 113.27 121.02 122.03 171.56
Dividend Payout % 17% 19% 12% 11% 7% 8% 9% 4% 4% 5% 5% 10%
Compounded Sales Growth
10 Years: 16%
5 Years: 16%
3 Years: 2%
TTM: 53%
Compounded Profit Growth
10 Years: 27%
5 Years: 42%
3 Years: 6%
TTM: 46%
Stock Price CAGR
10 Years: 58%
5 Years: 37%
3 Years: 51%
1 Year: -39%
Return on Equity
10 Years: 16%
5 Years: 16%
3 Years: 14%
Last Year: 13%

Balance Sheet

Figures in Rs. Crores

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022
3 3 3 3 3 3 3 3 3 3 3 3 3
Reserves 25 28 35 42 54 65 80 110 174 224 269 302 324
2 3 1 0 0 1 0 1 0 0 0 0 0
6 7 8 8 11 13 11 31 36 43 57 61 63
Total Liabilities 37 41 47 54 69 82 94 144 214 270 329 367 390
11 11 10 9 18 20 35 37 38 41 51 147 146
CWIP 0 1 0 4 1 12 0 1 6 16 68 8 6
Investments 14 14 14 18 19 18 33 53 116 163 154 151 160
11 16 23 23 30 31 26 54 54 50 56 61 77
Total Assets 37 41 47 54 69 82 94 144 214 270 329 367 390

Cash Flows

Figures in Rs. Crores

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
1 1 2 9 9 14 12 10 24 45 30 44
-0 -1 0 -7 -8 -13 -11 -10 -0 -43 -29 -42
-1 -0 -3 -2 -1 -1 -2 -1 -23 -2 -2 -2
Net Cash Flow 0 0 0 0 0 0 -0 0 0 0 -1 -0

Ratios

Figures in Rs. Crores

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 73 81 102 96 114 97 83 135 85 69 85 97
Inventory Days 162 190 133 117 96 117 125 118 122 131 148 233
Days Payable 93 117 79 71 94 104 70 170 73 110 118 227
Cash Conversion Cycle 142 154 155 142 116 110 138 83 133 89 115 103
Working Capital Days 85 109 115 108 110 95 92 109 100 75 60 81
ROCE % 18% 14% 30% 30% 32% 25% 12% 29% 27% 21% 20% 17%

Shareholding Pattern

Numbers in percentages

Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
66.71 66.71 66.71 66.97 66.97 66.97 66.97 66.97 66.97 66.97 66.97 66.97
0.00 0.00 0.00 0.01 0.07 0.08 0.04 0.00 0.00 0.00 0.00 0.01
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00
33.29 33.29 33.29 33.02 32.96 32.95 33.00 33.03 33.03 33.03 33.04 33.02

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings